Global CRO ICON plc, a provider of drug and device development and commercialization services to clinical sponsors announced the acquisition of MeDiNova Research, a site network with research sites in targeted markets in Europe and Africa. ICON, in competing against...
ICON is a tier-1 contract research organization (CRO). Computer Weekly reports they now manage nearly 100,000 patients participating in clinical trials at about 100 locations worldwide. ICON employs 14,000 and currently enjoys a $7.1 billion market capitalization....
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
